Internal Medicine, Gastroenterology · Bellingham, WA
NPI
1093847949
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2979 Squalicum Pkwy, Suite 301
Bellingham, WA, 98225
Phone (360) 734-1420
Groups this clinician bills Medicare through
Medicare paid, 2024
$175K
6,178 services
Medicare patients, 2024
440
Average age 73
Drug cost, 2024
$205K
926 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd N Witte was code 88305 (surgical pathology examination), 341 times for 206 patients. In total Todd N Witte billed 6,178 services in 44 codes, and Medicare paid $175K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 341 | 206 | $24.87 | $8,480 |
| 45385 Colonoscopy - Lesion Removal | Facility | 171 | 171 | $214.90 | $37K |
| 99214 Office E&M - Established | Office | 128 | 100 | $91.28 | $12K |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 111 | 109 | $4.78 | $530 |
| 99204 Office E&M - New | Office | 54 | 54 | $124.02 | $6,697 |
| 99213 Office E&M - Established | Office | 52 | 48 | $67.08 | $3,488 |
| 43239 Upper GI Endoscopy | Facility | 46 | 45 | $64.16 | $2,952 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 36 | 36 | $183.61 | $6,610 |
| 43248 Upper GI Endoscopy | Facility | 28 | 28 | $101.93 | $2,854 |
| 45380 Lower GI Endoscopy - Other | Facility | 23 | 23 | $103.87 | $2,389 |
| 99215 Office E&M - Established | Office | 17 | 16 | $119.15 | $2,025 |
| 99203 Office E&M - New | Office | 16 | 16 | $66.31 | $1,061 |
| 99222 Hospital E&M - Initial | Facility | 15 | 14 | $99.35 | $1,490 |
| 43235 Upper GI Endoscopy | Facility | 15 | 15 | $77.23 | $1,158 |
By year: 2022 $189K for 8,618 services; 2023 $160K for 8,609 services; 2024 $175K for 6,178 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 341 | 206 | $24.87 | $8,480 |
Medicare prescription drug claims, 2024
In 2024, the drug Todd N Witte prescribed most often to Medicare patients was Omeprazole, with 212 prescriptions and refills. In total Todd N Witte wrote 926 Medicare prescriptions that cost $205K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 212 | 536 | 71 | $2,988 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 153 | 153 | 153 | $21K |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 61 | 61 | 59 | $1,682 |
| Pantoprazole Sodium Generic | 35 | 85 | 15 | $913 |
| Colestipol Hcl Generic | 33 | 61 | 13 | $1,675 |
| Spironolactone Generic | 28 | 56 | Under 11 | $380 |
| Famotidine Generic | 28 | 60 | Under 11 | $610 |
| Mesalamine Generic | 25 | 65 | Under 11 | $27K |
| Sucralfate Generic | 22 | 28 | 12 | $1,635 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 18 | 18 | 17 | $1,106 |
| Furosemide Generic | 14 | 26 | Under 11 | $137 |
| Esomeprazole Magnesium Generic | 13 | 39 | Under 11 | $673 |
| Ondansetron Odt Ondansetron | 13 | 13 | Under 11 | $102 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 12 | 12 | 11 | $258 |
| Xifaxan Rifaximin | 12 | 12 | Under 11 | $37K |
Brand drugs: - claims; generic drugs: 607 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Todd N Witte were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.